RAB5A (Ras-related protein Rab-5A)

News alerts, weekly reports and conference planners

Entrez ID:

RAB5A expression	Breast Cancer	RAB5A expression	Breast Cancer	ado-trastuzumab emtansine Sensitive: B - Late Trials ado-trastuzumab emtansine Sensitive : B	ado-trastuzumab emtansine Sensitive: B - Late Trials ado-trastuzumab emtansine Sensitive : B
RAB5A expression	Breast Cancer	RAB5A expression	Breast Cancer	pertuzumab + ado-trastuzumab emtansine Sensitive: C3 – Early Trials pertuzumab + ado-trastuzumab emtansine Sensitive : C3	pertuzumab + ado-trastuzumab emtansine Sensitive: C3 – Early Trials pertuzumab + ado-trastuzumab emtansine Sensitive : C3
RAB5A expression	HER2 Positive Breast Cancer	RAB5A expression	HER2 Positive Breast Cancer	fam-trastuzumab deruxtecan-nxki Sensitive: D – Preclinical fam-trastuzumab deruxtecan-nxki Sensitive : D	fam-trastuzumab deruxtecan-nxki Sensitive: D – Preclinical fam-trastuzumab deruxtecan-nxki Sensitive : D
RAB5A expression	HER2 Positive Breast Cancer	RAB5A expression	HER2 Positive Breast Cancer	sacituzumab govitecan-hziy Sensitive: D – Preclinical sacituzumab govitecan-hziy Sensitive : D	sacituzumab govitecan-hziy Sensitive: D – Preclinical sacituzumab govitecan-hziy Sensitive : D

Associations(4)